Furthermore, in an evaluation performed six months after vaccination, patients with IBD treated with anti-TNF demonstrated significantly impaired serological responses, specifically, more seronegativity, decreased specific circulating B cells and cross-reactivity compared to patients untreated with anti-TNF [42]. Here, TNF is linked to inflammatory bowel disease.